Literature DB >> 17966295

Acute ischemic stroke review.

Janice L Hinkle1, Mary McKenna Guanci.   

Abstract

More than 700,000 people have a stroke each year in the United States. A diagnosis of stroke formerly elicited a nihilistic approach, but this has substantially changed in the last decade. Currently, time is brain, and it is important for all disciplines to work together to initiate acute stroke protocols in the emergency department and identify patients within the therapeutic time window for thrombolytic and neuroprotective therapies. Evolving protocols, management, and nursing care all have important implications during the acute phase of ischemic stroke. Patient and family education on risk reduction must also be addressed by the entire healthcare team.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17966295     DOI: 10.1097/01376517-200710000-00005

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  13 in total

1.  Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.

Authors:  Manbok Choi; Jungju Oh; Taiyoun Rhim; Minhyung Lee
Journal:  Pharm Res       Date:  2016-06-20       Impact factor: 4.200

2.  Using Extracellular Circulating microRNAs to Classify the Etiological Subtypes of Ischemic Stroke.

Authors:  YaXing Gui; ZhongPing Xu; Tao Jin; LiSan Zhang; LiLi Chen; Bin Hong; Fei Xie; Wen Lv; XingYue Hu
Journal:  Transl Stroke Res       Date:  2018-09-04       Impact factor: 6.829

3.  SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.

Authors:  Yuhang Jiang; Anna M Brynskikh; Devika S-Manickam; Alexander V Kabanov
Journal:  J Control Release       Date:  2015-06-18       Impact factor: 9.776

4.  Cellular-resolution monitoring of ischemic stroke pathologies in the rat cortex.

Authors:  Sergiy Chornyy; Aniruddha Das; Julie A Borovicka; Davina Patel; Hugh H Chan; John K Hermann; Thomas C Jaramillo; Andre G Machado; Kenneth B Baker; Hod Dana
Journal:  Biomed Opt Express       Date:  2021-07-16       Impact factor: 3.732

5.  Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions.

Authors:  Yancy Ferrer-Acosta; Maxine N Gonzalez-Vega; David E Rivera-Aponte; Solianne M Martinez-Jimenez; Antonio H Martins
Journal:  J Vis Exp       Date:  2017-10-21       Impact factor: 1.355

Review 6.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Authors:  Christos Tapeinos; Matteo Battaglini; Gianni Ciofani
Journal:  J Control Release       Date:  2017-08-26       Impact factor: 9.776

7.  Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells.

Authors:  Doreen M Reich; Susann Hau; Tobias Stahl; Markus Scholz; Wilfried Naumann; Frank Emmrich; Johannes Boltze; Manja Kamprad
Journal:  BMC Neurosci       Date:  2008-09-19       Impact factor: 3.288

8.  Scutellarin regulates the Notch pathway and affects the migration and morphological transformation of activated microglia in experimentally induced cerebral ischemia in rats and in activated BV-2 microglia.

Authors:  Yun Yuan; Parakalan Rangarajan; Enci Mary Kan; Yajun Wu; Chunyun Wu; Eng-Ang Ling
Journal:  J Neuroinflammation       Date:  2015-01-20       Impact factor: 8.322

9.  A mechanistic model for atherosclerosis and its application to the cohort of Mayak workers.

Authors:  Cristoforo Simonetto; Tamara V Azizova; Zarko Barjaktarovic; Johann Bauersachs; Peter Jacob; Jan Christian Kaiser; Reinhard Meckbach; Helmut Schöllnberger; Markus Eidemüller
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

10.  The efficacy of citroline in the treatment of ischemic stroke and primary hypertensive intracereral hemorrhage; a review article.

Authors:  Seyed Ali Mousavi; Fariborz Khorvash; Tahereh Hoseini
Journal:  ARYA Atheroscler       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.